Back to Network
3
Shared Docs
3
Same-Page
9 / 3
Mentions
Document Mentions (3 shared documents)
4 mentions1 same-page
Page ?Same page
From: Richard Kahn To: Jeffrey Epstein [email protected]> Subject: Mrk Date: Wed, 02 Sep 2015 10:52:53 +0000 PivIRK Chart MRK data by YCharts 4. Merck & Co. (MRK) Credit Suisse R
From: Richard Kahn To: Jeffrey Epstein [email protected]> Subject: Mrk Date: Wed,
From: Richard Kahn To: Jeffrey Epstein [email protected]> Subject: Mrk Dat
t MRK data by YCharts 4. Merck & Co. (MRK) Credit Suisse Rating, Target Price: Neutral, S61 Potential Stock Upside: 11% Upcoming Catalyst: MRK's Januvia franchise will likely feel pressure from the positive EMPA-REG OUTCOME data but we expect MRK to get a boost from FDA approval of Keytruda in 2nd li
4 mentions1 same-page
Page ?Same page
From: Barrett, Paul S Sent: Wednesday, February 13, 2013 5:41 PM To: Jeffrey Epstein Cc: Weissend, Renee E; Ens, Amanda Subject: An idea <=iv class="WordSectionl"> Jeff=ey &=bsp; I do not =hink we have enough equity risk in the po
ednesday, February 13, 2013 5:41 PM To: Jeffrey Epstein Cc: Weissend, Renee E; Ens, Amanda Subject: A
Sent: Wednesday, February 13, 2013 5:41 PM To: Jeffrey Epstein Cc: Weissend, Renee E; Ens, Amanda Sub
. International revenues represent 62% o= total, while the U.S. represents - 38%. Highest selling products inc=ude: Singulair (asthma/allergies) and Januvia (diabetes)=/p> • =nbsp; Pullback presents opportunity in a favored sector (the cheapest d=fensive sector) — </=pan>MRK is down -14% over last 4 m
4 mentions1 same-page
Page ?Same page
From: Jeffrey Epstein <[email protected]> Sent: Wednesday, February 13, 2013 5:48 PM To: Barrett, Paul S Subject: Re: An idea ok On Wed, Feb 13, 2013 at 12:41
ruary 13, 2013 5:48 PM To: Barrett, Paul S Subject: Re: An idea ok On Wed, Feb 13, 2013 at 12:41 PM, Bar=ett, Paul S <I <mailto > wrote:<=r> Jeffrey I do not think we have enough equity ri=k in the portfolio right now. While we feel very good about our mortgages =nd credit exposure, the upside i
From: Jeffrey Epstein <[email protected]> Sent: Wednesday, Februa
. International revenues represent 62% of total, while the U.S. represents - 38%. Highest selling products include= Singulair (asthma/allergies) and Januvia (diabetes)<=p> • Pullback presents opportunity i= a favored sector (the cheapest defensive sector)<=> - MRK is down -14% over last 4 month= vs. P
Sponsored
Mutual Connections (5)
Entities connected to both Jeffrey Epstein and Januvia
